Ignite Creation Date:
2024-05-06 @ 4:27 PM
Last Modification Date:
2024-10-26 @ 2:10 PM
Study NCT ID:
NCT04993014
Status:
RECRUITING
Last Update Posted:
2021-08-06
First Post:
2021-07-21
Brief Title:
Circulating Tumor Cells and Treatment De-escalation After Neoadjuvant Therapy for HER2 Positive Breast Cancer
Sponsor:
AC Camargo Cancer Center
Organization:
AC Camargo Cancer Center
Organization Data
Organization:
AC Camargo Cancer Center
Class:
OTHER
Study ID:
286120
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AC Camargo Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
Marcelle Goldner Cesca
Responsible Party Title:
Clinical Oncologist
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
AC Camargo Cancer Center
Old Name:
None
Old Organization:
None